Search Results

You searched for : TreatmentforHIV  

	ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE drug delivery technology Halozyme’s drug delivery technology provides the opportunity to administer large volume subcutaneous injections that may enable dosing intervals of every three months and up ... Jun 22
	ViiV Healthcare receives EU Marketing Authorisation for Tivicay, a treatment for children living with HIV in Europe Tivicay contains dolutegravir, an integrase strand transfer inhibitor for use in combination with other antiretroviral agents for the treatment of HIV... Jan 15
	Strides receives USFDA approval for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug, Truvada Tablets, 200 mg/300 mg, of Gilead Sciences... Jan 15
	ViiV Healthcare receives EU Marketing Authorisation for the first-ever dispersible-tablet formulation of dolutegravir, Tivicay ... Jan 13
	ViiV Healthcare announces the Marketing Authorisation of the first complete long-acting injectable HIV treatment in Europe This authorization represents the first time people living with HIV in Europe may be able to receive a long-acting injectable treatment that removes the ... Dec 21
	ViiV Healthcare announces positive CHMP opinion for Rukobia, for the treatment of adults with multidrug-resistant HIV Fostemsavir addresses a critical unmet need in HIV care for those with little to no treatment options left.... Dec 11
	Merck Advances Phase 3 Trial to Evaluate Investigational Islatravir as Once-Monthly Oral PrEP for Women at High Risk for Acquiring HIV-1 Collaboration with the Bill & Melinda Gates Foundation Seeks to Bring Forward a New HIV Prevention Option with Focus on Women... Nov 16
	ViiV Healthcare receives positive CHMP opinion for long-acting regimen for the treatment of HIV ViiV Healthcare announced CHMP issed positive opinion recommending Vocabria in combination with Rekambys and Edurant for the treatment of HIV-1 ... Oct 16
	Merck Announces Week 96 Data from Phase 2b Study Evaluating Islatravir With Doravirine for HIV-1 Merck, today announced Week 96 data from the Phase 2b trial evaluating the efficacy and safety of islatravir for HIV-1 infections... Oct 08
9 Matching result(s) found!

Trending Now
	High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
	Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026
	SRM College of Pharmacy Hosts Two-Day National Pharmaceutical ConferenceAugust 21, 2026
	Atomy India Joins Hands with the Paralympic Committee of India as OfficialNutrition and Wellness PartnerAugust 21, 2026
	Thumbay International Pathway - MD Program with Installments and a Direct Route to Residency in RomaniaAugust 21, 2026
	THIP wins ‘Breakthrough Digital Patient Education Initiative’ award at India Vaccine Leaders Conclave in PuneAugust 21, 2026
	Three Watermelons, a Mannequin Head and a PS5: What India Left Behind on Intercity BusesAugust 21, 2026
	Evaluating Thyroid Nodules: Fine Needle Aspiration Cytology (FNAC) and Bethesda ClassificationAugust 21, 2026
	Clinical Approaches to Acute Kidney Injury (AKI): Biomarkers, Staging, and Renal Replacement TherapyAugust 21, 2026
	Diabetes Care in India: Understanding the Crisis, Bridging the Gaps, and Building a Healthier FutureAugust 21, 2026
	Diabetes Management: Lifestyle Changes That Make a Real DifferenceAugust 21, 2026
	TagMango introduces New AI capabilities for creator businesses at RISE 2026August 20, 2026
	AFib: The Irregular Heartbeat We Need to Stop IgnoringAugust 20, 2026
	Nanavati Max Launches Dedicated Cancer Helpline to Support Patients and Families In Their Cancer JourneyAugust 20, 2026
	Modern Interventions in Maxillofacial Trauma: Soft Tissue Repair and Internal Fixation FrameworksAugust 20, 2026
	Building Disaster Recovery Protocols for Hospital IT: Ensuring 99.9% Uptime During OutagesAugust 20, 2026
	Importance of Nutrition: Why What You Eat Shapes Your Health, Energy, and FutureAugust 20, 2026
	Stress Management: Causes, Symptoms, Signs and Effective Relief StrategiesAugust 20, 2026
	Vulnerable families in Chennai receive free eye check-up in collaborative camp from SOS Children’s Villages India and Dr Agarwals Eye HospitalAugust 19, 2026
	Kauvery Hospital Builds an Integrated Epilepsy-Care Network Across Its Chennai HospitalsAugust 19, 2026